What is the therapeutic potential of exosomes?
Organicell™ is a clinical-stage biopharmaceutical company that has developed its lead biologic drug called Zofin™. This drug is an acellular biologic therapeutic manufactured to retain naturally occurring microRNAs. Zofin™ contains over 300 growth factors, cytokines, chemokines, and exosomes derived from perinatal tissues. We believe that the key to Zofin’s™ therapeutic effect is in the intra-exosome cargo. Zofin™ is currently being studied in clinical trials for COVID-19 and other conditions, such as COPD and Osteoarthritis.
Based in South Florida, Organicell™ is a publicly traded biotechnology company committed to the research, development and manufacture of new biologic medicine, with a focus on current and potential regenerative therapeutics. Organicell™ is the leading, fully integrated Biologic Medicine Company. Our mission is to transform regenerative medicine through the development of novel nano-technologies and to become the health care incubator for the next generation of biologic medicines.